Cargando…

Racial disparities in treatment patterns and clinical outcomes in patients with HER2-positive metastatic breast cancer

Data characterizing demographics, treatment patterns, and clinical outcomes in black patients with human epidermal growth factor receptor 2 (HER2)-positive metastatic breast cancer (MBC) are limited. registHER is a large, observational cohort study of patients (n = 1,001) with HER2-positive MBC diag...

Descripción completa

Detalles Bibliográficos
Autores principales:	Rugo, Hope S., Brufsky, Adam M., Yood, Marianne Ulcickas, Tripathy, Debu, Kaufman, Peter A., Mayer, Musa, Yoo, Bongin, Abidoye, Oyewale O., Yardley, Denise A.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Springer US 2013
Materias:	Epidemiology
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3824350/ https://www.ncbi.nlm.nih.gov/pubmed/24062208 http://dx.doi.org/10.1007/s10549-013-2697-5

Ejemplares similares

Treatment patterns and clinical outcomes for patients with de novo versus recurrent HER2-positive metastatic breast cancer
por: Yardley, Denise A., et al.
Publicado: (2014)

Treatment patterns and clinical outcomes in elderly patients with HER2-positive metastatic breast cancer from the registHER observational study
por: Kaufman, Peter A., et al.
Publicado: (2012)

Long-term survivor characteristics in HER2-positive metastatic breast cancer from registHER
por: Yardley, D A, et al.
Publicado: (2014)

De Novo Versus Recurrent HER2‐Positive Metastatic Breast Cancer: Patient Characteristics, Treatment, and Survival from the SystHERs Registry
por: Tripathy, Debu, et al.
Publicado: (2019)

The SystHERs registry: an observational cohort study of treatment patterns and outcomes in patients with human epidermal growth factor receptor 2–positive metastatic breast cancer
por: Tripathy, Debu, et al.
Publicado: (2014)

Assessing the discordance rate between local and central HER2 testing in women with locally determined HER2-negative breast cancer
por: Kaufman, Peter A, et al.
Publicado: (2014)

Cardiovascular disease risk and androgen deprivation therapy in patients with localised prostate cancer: a prospective cohort study
por: Haque, Reina, et al.
Publicado: (2017)

Vitamin D and Racial Disparity in Albuminuria: NHANES 2001–2006
por: Fiscella, Kevin A., et al.
Publicado: (2011)

Cross-sectional analysis of place-based and racial disparities in hospitalisation rates by disease category in California in 2001 and 2011
por: Raphael, Eva, et al.
Publicado: (2019)

Racial and ethnic disparities in the refusal of surgical treatment in women 40 years and older with breast cancer in the USA between 2010 and 2017
por: Fwelo, Pierre, et al.
Publicado: (2022)

Using Decomposition Analysis to Identify Modifiable Racial Disparities in the Distribution of Blood Pressure in the United States
por: Basu, Sanjay, et al.
Publicado: (2015)

Modeling the impact of racial and ethnic disparities on COVID-19 epidemic dynamics
por: Ma, Kevin C, et al.
Publicado: (2021)

Racial and ethnic disparities in SARS-CoV-2 pandemic: analysis of a COVID-19 observational registry for a diverse US metropolitan population
por: Vahidy, Farhaan S, et al.
Publicado: (2020)

575 Are There Racial Disparities in Burn Center Care?
por: Bessey, Palmer Q, et al.
Publicado: (2022)

COVID-19-related state-wise racial and ethnic disparities across the USA: an observational study based on publicly available data from The COVID Tracking Project
por: Xian, Zhaoying, et al.
Publicado: (2021)

HER2 status and breast cancer therapy: recent advances
por: Tripathy, Debu
Publicado: (2009)

Real-world treatment in patients with HER2+ metastatic breast cancer: Treatment decisions in HER2+ mBC
por: Colomer, R., et al.
Publicado: (2017)

Emerging treatment options for the management of brain metastases in patients with HER2-positive metastatic breast cancer
por: Chien, A. Jo, et al.
Publicado: (2012)

Measuring health disparities: a comparison of absolute and relative disparities
por: Moonesinghe, Ramal, et al.
Publicado: (2015)

Racial/ethnic differences in the outcomes of patients with metastatic breast cancer: contributions of demographic, socioeconomic, tumor and metastatic characteristics
por: Ren, Jin-Xiao, et al.
Publicado: (2018)

Racial inequities in second-line treatment and overall survival among patients with metastatic breast cancer
por: Whitaker, Kristen D., et al.
Publicado: (2022)

Differential presentation and survival of de novo and recurrent metastatic breast cancer over time: 1990–2010
por: Malmgren, Judith A., et al.
Publicado: (2017)

Racial Disparities in Health Care With Timing to Amputation Following Diabetic Foot Ulcer
por: Miller, Taavy A., et al.
Publicado: (2022)

Racial disparities in healthcare provider advice to quit smoking
por: Landrine, Hope, et al.
Publicado: (2018)

Sustained Hyperglycemia Among Patients With Diabetes: What matters when action is needed?
por: Lafata, Jennifer E., et al.
Publicado: (2009)

EGFR-Targeted Therapeutics: Focus on SCCHN and NSCLC
por: Sattler, Martin, et al.
Publicado: (2008)

Real-world study of overall survival with palbociclib plus aromatase inhibitor in HR+/HER2− metastatic breast cancer
por: Rugo, Hope S., et al.
Publicado: (2022)

40339 Characterizing the impact of social and structural determinants of health on racial and ethnic disparities in COVID-19 outcomes using electronic health record (EHR) data
por: Heery, Lauren, et al.
Publicado: (2021)

Age, gender, and racial differences in incidence and survival in primary CNS lymphoma
por: Villano, J L, et al.
Publicado: (2011)

Diagnostic value of core needle biopsy for determining HER2 status in breast cancer, especially in the HER2-low population
por: Chen, Ruixian, et al.
Publicado: (2022)

Immune cell profiles of metastatic HER2-positive breast cancer patients according to the sites of metastasis
por: Honkanen, Tiia J., et al.
Publicado: (2021)

Trastuzumab therapy duration in HER2-positive de novo metastatic breast cancer: 1999–2018
por: Kaplan, Henry G., et al.
Publicado: (2022)

Racial Disparity of Eye Examinations Among the U.S. Working-Age Population With Diabetes: 2002–2009
por: Shi, Qian, et al.
Publicado: (2014)

Racial and ethnic differences among amyotrophic lateral sclerosis cases in the United States
por: Rechtman, Lindsay, et al.
Publicado: (2015)

The characterization, management, and future considerations for ErbB-family TKI-associated diarrhea
por: Rugo, Hope S., et al.
Publicado: (2019)

Comparative effectiveness of first-line palbociclib plus letrozole versus letrozole alone for HR+/HER2− metastatic breast cancer in US real-world clinical practice
por: DeMichele, Angela, et al.
Publicado: (2021)

Potential misinterpretations caused by collapsing upper categories of comorbidity indices: An illustration from a cohort of older breast cancer survivors
por: Ahern, Thomas P, et al.
Publicado: (2009)

Multi-database study of multiple sclerosis: identification, validation and description of MS patients in two countries
por: Persson, Rebecca, et al.
Publicado: (2019)

Prevalence of and Racial Disparities in Risk Factor Control in Older Adults With Diabetes: The Atherosclerosis Risk in Communities Study
por: Parrinello, Christina M., et al.
Publicado: (2015)

Real-world comparative effectiveness of palbociclib plus letrozole versus letrozole in older patients with metastatic breast cancer
por: Rugo, Hope S., et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_ujlvt082ktiv58kstbt6jni4ef